Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 14, 2019 10:00 ET | Source: Surrozen, Inc.

Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidates

-- Anna Berkenblit, MD, appointed to Surrozen Board of Directors -- SAN FRANCISCO, March 14, 2019 (GLOBE NEWSWIRE) -- Surrozen Inc., a company discovering and developing novel antibodies for...